Sign Up to like & get
recommendations!
0
Published in 2023 at "Ocular immunology and inflammation"
DOI: 10.1080/09273948.2023.2189456
Abstract: PURPOSE To report a case of bilateral acute uveitis following the first and subsequent doses of Oxford-AstraZeneca COVID-19 vaccination. METHOD A case report. RESULTS A 74-year-old Caucasian woman was presented with a one-day history of…
read more here.
Keywords:
uveitis following;
astrazeneca;
astrazeneca covid;
covid vaccination ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz260.043
Abstract: Abstract Background Approximately 20%–30% of patients (pts) with EGFR mutation-positive NSCLC present with CNS metastases at the time of diagnosis of advanced disease. CNS metastases are associated with a poor prognosis. Osimertinib is a third-generation,…
read more here.
Keywords:
research;
cns metastases;
astrazeneca;
cns ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.702
Abstract: Patients with systemic lupus erythematosus (SLE) who received anifrolumab, a type I interferon receptor antibody, had greater BILAG–based Composite Lupus Assessment (BICLA) response rates vs placebo at Week (W)52 in the phase 2 MUSE1 and…
read more here.
Keywords:
response;
placebo;
bicla;
astrazeneca ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "International Journal of Gynecological Cancer"
DOI: 10.1136/ijgc-2019-esgo.28
Abstract: Introduction/Background In ARIEL3, rucaparib maintenance treatment significantly improved progression-free survival (PFS) vs placebo in all patient populations, regardless of biomarker status (Coleman et al. Lancet. 2017;390:1949–61). This subgroup analysis examined the effect of the stratification…
read more here.
Keywords:
pfi;
astrazeneca;
clovis;
clovis astrazeneca ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2022.989730
Abstract: Vaccine-induced thrombotic thrombocytopenia (VITT) is a well-known complication of adenoviral vector COVID-19 vaccines including ChAdOx1 nCoV-19 (AstraZeneca) and Ad26. COV2.S (Janssen, Johnson & Johnson). To date, only a few cases of mRNA COVID-19 vaccine such…
read more here.
Keywords:
hemorrhage;
vaccine;
astrazeneca;
thrombocytopenia ... See more keywords